Start Your Treatment

I wanted more than a standard pathway for Stage II breast cancer. Canceria looked at my treatment history and situation to consider what might be relevant to my case. That individual attention made exploring my options feel worthwhile.

We weren't looking to second-guess the plan; we just didn't want to wonder later whether another relevant direction had gone unexplored. I appreciated that Canceria made room for that question while the option we had remained on the table.

A coworker keeps forwarding diet charts and frequency machines. I stopped reading those months ago. What drew me to Canceria was the distinction it draws between actual evidence and the noise online, and whether any of that evidence has anything to do with my lung cancer specifically.

I respect that Canceria focused on what might matter in my specific case and spoke plainly about the science. That's more useful to me than comfort talk.

Enough with positive-thinking speeches. Canceria actually looked at what might be worth investigating for my prostate cancer. That's all I wanted.

Some days I lose a word mid-sentence on a work call, and a colleague jumps in to finish for me. She means well. Still, I want to speak for myself, and I wanted the review of my glioma to account for how complicated it is rather than smooth it into something simple because I take longer to get the words out. Canceria's assessment left room for both the complexity and my own voice.

My son offered to come; I said not yet. I wanted to understand my prostate cancer on my own terms first. Canceria let me start without promising a fast answer, and that mattered.

With recurrence, my file has years in it, and I'm tired of repeating the early chapters to someone who only reads the latest page. I appreciated that Canceria's review considered the whole history, not just the newest scan. Recurrent breast cancer isn't a fresh start; it's a continuation, and this time I felt that was understood. That made going through it all again feel worthwhile.

My mother keeps a notebook of every appointment and every rupee spent getting here. I didn't want another forwarded article claiming something works for cancer in general. I wanted to know how actual published research on Hodgkin lymphoma connects to one specific case, mine, and Canceria is the first place that made that distinction clearly instead of flattening it into generic hope.

My sister used to forget half of what the doctors told us; now she writes it down and asks the questions I freeze on in the room. I expected an outside review to stop at the diagnosis. Instead, Canceria engaged with the details of my pancreatic cancer, its history and context. It felt less like being filed and more like being considered. I didn't expect to be this moved by an approach, but I am. It changed what I think a serious review can be.